Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic Performance Evaluation of 213Bi-Labelled Aminopeptidase N (APN/CD13)-Affine NGR-Motif ([213Bi]Bi-DOTAGA-cKNGRE) in Experimental Tumour Model: A Treasured Tailor for Oncology.
Képes Z, Arató V, Szabó JP, Gyuricza B, Szücs D, Hajdu I, Fekete A, Bruchertseifer F, Szikra D, Trencsényi G. Képes Z, et al. Among authors: gyuricza b. Pharmaceutics. 2023 Feb 1;15(2):491. doi: 10.3390/pharmaceutics15020491. Pharmaceutics. 2023. PMID: 36839813 Free PMC article.
Synthesis, Physicochemical, Labeling and In Vivo Characterization of 44Sc-Labeled DO3AM-NI as a Hypoxia-Sensitive PET Probe.
Szücs D, Csupász T, Szabó JP, Kis A, Gyuricza B, Arató V, Forgács V, Vágner A, Nagy G, Garai I, Szikra D, Tóth I, Trencsényi G, Tircsó G, Fekete A. Szücs D, et al. Among authors: gyuricza b. Pharmaceuticals (Basel). 2022 May 26;15(6):666. doi: 10.3390/ph15060666. Pharmaceuticals (Basel). 2022. PMID: 35745585 Free PMC article.
61Cu-Labelled radiodiagnostics of melanoma with NAPamide-targeted radiopharmaceutical.
Kálmán-Szabó I, Bunda S, Lihi N, Szaniszló Z, Szikra D, Szabó Péliné J, Fekete A, Gyuricza B, Szücs D, Papp G, Trencsényi G, Kálmán FK. Kálmán-Szabó I, et al. Among authors: gyuricza b. Int J Pharm. 2023 Feb 5;632:122527. doi: 10.1016/j.ijpharm.2022.122527. Epub 2022 Dec 23. Int J Pharm. 2023. PMID: 36566825
In Vivo evaluation of newly synthesized 213Bi-conjugated alpha-melanocyte stimulating hormone (α-MSH) peptide analogues in melanocortin-1 receptor (MC1-R) positive experimental melanoma model.
Kálmán-Szabó I, Képes Z, Fekete A, Vágner A, Nagy G, Szücs D, Gyuricza B, Arató V, Varga J, Kárpáti L, Garai I, Mándity I, Bruchertseifer F, Elek J, Szikra D, Trencsényi G. Kálmán-Szabó I, et al. Among authors: gyuricza b. J Pharm Biomed Anal. 2023 May 30;229:115374. doi: 10.1016/j.jpba.2023.115374. Epub 2023 Mar 28. J Pharm Biomed Anal. 2023. PMID: 37001274 Free article.
Evaluation of the therapeutic efficacy of 213Bi-labelled DOTA-conjugated alpha-melanocyte stimulating hormone peptide analogues in melanocortin-1 receptor positive preclinical melanoma model.
Csikos C, Képes Z, Fekete A, Vágner A, Nagy G, Gyuricza B, Arató V, Kárpáti L, Mándity I, Bruchertseifer F, Halmos G, Szikra D, Trencsényi G. Csikos C, et al. Among authors: gyuricza b. Int J Pharm. 2023 Sep 25;644:123344. doi: 10.1016/j.ijpharm.2023.123344. Epub 2023 Aug 25. Int J Pharm. 2023. PMID: 37634663 Free article.
12 results